HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced that the U.S. Food and Drug ...
New York, Dec. 06, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "ECG Cable & ECG Lead wires Market Research Report by Material, by Machine Type, by Patient Care ...
HeartBeam BEAT recently secured FDA 510(k) clearance for its first-of-its-kind, cable-free synthesized 12-lead ECG technology, marking a major inflection point in the company’s mission to modernize ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results